Existing drug is shown to inhibit SARS-CoV-2 virus
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.
Jul 21, 2021
0
236
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.
Jul 21, 2021
0
236
The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just a few years ago, a pair of recent ...
Aug 24, 2023
1
99
Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading cause of vision loss in Americans ...
Jul 20, 2020
0
111
A short, simple and safe drug treatment developed at Tel Aviv University reduced the risk of the spread of cancer metastases after surgery to remove the primary tumor—according to the first clinical study of its kind conducted ...
Dec 6, 2022
0
155
A breakthrough in understanding a biological process that causes many common cancers including lung and breast cancer opens up a whole new realm of possibilities for the development of improved cancer drugs. The results are ...
May 13, 2011
0
0
A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin ...
Mar 18, 2015
4
146
Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance—atrial fibrillation (AF). The ...
Jul 18, 2022
0
312
In trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making ...
Aug 17, 2023
3
117
Most autoimmune diseases are easy to diagnose but hard to treat. A paper published today in Science proposes using your unique immune cell fingerprint to rapidly identify which treatments will work for your autoimmune disease.
Apr 7, 2022
0
507
Mutations in a vital class of regulatory molecules are an underappreciated cause of cancer because they impair the function of "G" proteins, a versatile and vast family of signaling switches that underlie innumerable biological ...